Trifluoroacetate mediated reduction of atherosclerosis in mice
Wei Tang, Audrey S. Black, Romana Moench, Katayoon Marzban, Juan Antonio Raygoza Garay, James J. Zheng, Louis Conway, Antonio F. M. Pinto, Christopher G. Parker, Alan Saghatelian, Luke J. Leman, M. Reza Ghadiri · 2026
Read Trifluoroacetate mediated reduction of atherosclerosis in mice by Wei Tang, Audrey S. Black, Romana Moench, Katayoon Marzban, Juan Antonio Raygoza Garay, James J. Zheng, Louis Conway, Antonio F. M. Pinto, Christopher G. Parker, Alan Saghatelian, Luke J. Leman, M. Reza Ghadiri (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13635227.txt.
Description
Tang and colleagues published in twenty twenty-six a mouse study with a surprising result about a common lab chemical. Trifluoroacetate, or TFA, is often treated as a harmless salt partner in made peptides. The team found TFA is in fact active in the body. It changed metabolism in three mouse strains and in cultured liver cells. It also spurred growth of peroxisomes, small cell parts that process fats.
In mice prone to artery plaque and fed a fatty diet, TFA lowered blood fats. Plaque in their arteries also grew less. Evidence pointed to a fat-sensing protein switch as the target. The authors warn that past peptide studies may need a second look. They also note wider questions about TFA exposure in the environment.
Catalog record
| CREATOR | Wei Tang, Audrey S. Black, Romana Moench, Katayoon Marzban, Juan Antonio Raygoza Garay, James J. Zheng, Louis Conway, Antonio F. M. Pinto, Christopher G. Parker, Alan Saghatelian, Luke J. Leman, M. Reza Ghadiri |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 132 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |